Significant Ownership of BCLS Fund III Investments, LP

Signature - Title
/s/ Andrew Hack - Andrew Hack, Partner of Bain Capital Life Sciences Investors, LLC
Location
Boston, MA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by BCLS Fund III Investments, LP.

Notify me when BCLS Fund III Investments, LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of BCLS Fund III Investments, LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
HTFL Heartflow, Inc. Common Stock, $0.001 par value per share 15% $419,004,998 12,448,158 BCLS Fund III Investments, LP 30 Sep 2025
NAMS NewAmsterdam Pharma Company N.V. Ordinary Shares, nominal value Euro 0.12 per share 4.7% $214,462,841 -$241,180,844 5,376,356 -53% BCLS Fund III Investments, LP 02 Dec 2025
DNTH DIANTHUS THERAPEUTICS, INC. Common Stock, $0.001 par value per share 3.1% $51,780,350 -$45,896,187 1,315,892 -47% BCLS Fund III Investments, LP 30 Sep 2025
CDTX CIDARA THERAPEUTICS, INC. Common Stock, $0.0001 par value per share 0% $0 -$668,786,766 0 -100% BCLS Fund III Investments, LP 31 Dec 2025

Schedules 13D/G Reported by BCLS Fund III Investments, LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.